在阻塞性睡眠呼吸暂停中发现生物标志物:研究前沿的文献测量绘图 (2000-2023)
Yanxia Zhao1, Deshang Chen2, Yunqiu Chu1
1Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Sleep Disordered Breathing, Shanghai, China; Otolaryngology Institute of Shanghai Jiao Tong University, Shanghai, China.
Respiratory medicine
|November 7, 2025
概括
全球对阻塞性睡眠呼吸暂停 (OSA) 生物标志物的研究正在增长,美国处于领先地位. 本分析确定了改善OSA诊断和治疗的关键贡献者和趋势.
科学领域:
- 睡眠医学 睡眠医学
- 生物标志物 生物标志物
- 图书统计学 图书统计学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种复杂,异质的疾病,具有诊断和治疗方面的挑战.
- 对于理解OSA的多样性而言,存在着有限的框架.
- 推进精确睡眠医学需要对OSA生物标志物的更深入理解.
研究的目的:
- 分析全球关于阻塞性睡眠呼吸暂停 (OSA) 生物标志物的研究成果.
- 确定研究热点,趋势和该领域的主要贡献者.
- 为未来的研究提供信息,以改善OSA诊断和预后.
主要方法:
- 采用了一个文献计量方法.
- 搜索科学网络核心集合 (2000-2023) 的OSA生物标志物研究.
- 使用VOSviewer,CiteSpace和R进行出版物,引文和合作的文献计量分析.
主要成果:
- 分析了1108个出版物,显示了20多年来研究成果和引用的持续增长.
- 美国在出版量和引用影响方面领先,与中国有着重要的合作关系.
- 主要贡献者包括戈扎尔·D博士 (作者),芝加哥大学 (机构),以及"睡眠"和"睡眠和呼吸"等期刊.
- 目前的研究趋势集中在并发症,致病机制和表型/内型指标上.
结论:
- 图书统计分析揭示了OSA生物标志物研究的关键研究趋势和主要贡献者.
- 这些发现可以指导未来的研究,以更好地理解OSA异质性.
- 这项研究可以改善OSA诊断,风险识别和预后预测,推进精确的睡眠医学.
相关概念视频
Sleep Apnea
464
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
464
Other Pulmonary Disorders
1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K


